Terms: = Liver cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Prognosis
25 results:
1. Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis.
Shen Z; Cai J; Tao L; Zheng J; Ye Z; Liu Y; Pan H; Wang Y; Xu J; Liang X
Cancer Gene Ther; 2023 Dec; 30(12):1663-1678. PubMed ID: 37828105
[TBL] [Abstract] [Full Text] [Related]
2. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract] [Full Text] [Related]
3. Protein succinylation associated with the progress of hepatocellular carcinoma.
Bai W; Cheng L; Xiong L; Wang M; Liu H; Yu K; Wang W
J Cell Mol Med; 2022 Nov; 26(22):5702-5712. PubMed ID: 36308411
[TBL] [Abstract] [Full Text] [Related]
4. sdha/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ.
Yuan T; Zhou T; Qian M; Du J; Liu Y; Wang J; Li Y; Fan G; Yan F; Dai X; Li X; Wu Y; Dong X; He Q; Zhu H; Yang B
Hepatology; 2023 Jul; 78(1):103-119. PubMed ID: 35713976
[TBL] [Abstract] [Full Text] [Related]
5. Contrast-enhanced magnetic resonance imaging perfusion can predict microvascular invasion in patients with hepatocellular carcinoma (between 1 and 5 cm).
Wu L; Yang C; Halim A; Rao S; Xu P; Feng W; Chen C; Ji Y; Zhu J; Zeng M
Abdom Radiol (NY); 2022 Sep; 47(9):3264-3275. PubMed ID: 35113174
[TBL] [Abstract] [Full Text] [Related]
6. Simple cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K; Yamashita K; Nakagawa A; Yamada K; Watanabe A; Mukohyama J; Saito M; Fujita M; Takiguchi G; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2021 Aug; 41(8):4117-4126. PubMed ID: 34281882
[TBL] [Abstract] [Full Text] [Related]
7. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
Hu H; Chi JC; Liu R; Zhai B
Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
[TBL] [Abstract] [Full Text] [Related]
8. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
Kwon MJ; Byeon S; Kang SY; Kim KM
Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
[TBL] [Abstract] [Full Text] [Related]
9. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.
Li J; Liang N; Long X; Zhao J; Yang J; Du X; Yang T; Yuan P; Huang X; Zhang J; He X; Xing J
Cancer Lett; 2019 Oct; 461():44-55. PubMed ID: 31278950
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Dobrescu AE; Basa SN; Cornianu M; Lazăr DC; Suciu SC; Tudor A; Viţa OC; Tarţă-Marcu DC; Barna RA; Lazăr OF
Rom J Morphol Embryol; 2019; 60(4):1243-1251. PubMed ID: 32239101
[TBL] [Abstract] [Full Text] [Related]
11. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
[No Abstract] [Full Text] [Related]
12. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract] [Full Text] [Related]
13. Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma.
Li GB; Zhang XL; Yuan L; Jiao QQ; Liu DJ; Liu J
PLoS One; 2013; 8(3):e60775. PubMed ID: 23556002
[TBL] [Abstract] [Full Text] [Related]
14. [A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer].
Takada J; Kenno S; Aoki T; Hamada H; Katsuki Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2326-9. PubMed ID: 20037411
[TBL] [Abstract] [Full Text] [Related]
15. Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation--eighteen months of follow-up: a case report.
Han YS; Choi DL; Park JB
Transplant Proc; 2008 Oct; 40(8):2835-6. PubMed ID: 18929876
[TBL] [Abstract] [Full Text] [Related]
16. [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Hwang JY; Jang BK; Kwon KM; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim GC; Kim YH; Choi JS; Kwon JH
Korean J Gastroenterol; 2005 Feb; 45(2):118-24. PubMed ID: 15725716
[TBL] [Abstract] [Full Text] [Related]
17. [A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1].
Fujito T; Goda F; Matsuyama J; Hojo S; Yano Y; Endo W; Yamazaki K; Maeura Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):293-6. PubMed ID: 12610882
[TBL] [Abstract] [Full Text] [Related]
18. mRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma.
Peng J; Cai S; Leng X; Mu D; Lu J; Chen H; Rui J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):487-90. PubMed ID: 12411150
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells.
Mou DC; Cai SL; Peng JR; Wang Y; Chen HS; Pang XW; Leng XS; Chen WF
Br J Cancer; 2002 Jan; 86(1):110-6. PubMed ID: 11857021
[TBL] [Abstract] [Full Text] [Related]
20. Clinical evaluation of hepatic arterial infusion of low dose-CDDP and 5-FU with hyperthermotherapy: a preliminary study for liver metastases from esophageal and gastric cancer.
Iwahashi M; Tanimura H; Nakamori M; Nagai Y; Hirabayashi N; Ueda K; Matsuda K; Tsunoda T; Yamaue H
Hepatogastroenterology; 1999; 46(28):2504-10. PubMed ID: 10522028
[TBL] [Abstract] [Full Text] [Related]
[Next]
